Jan 21 Johnson & Johnson has suspended international trials of a drug in the same class as an experimental drug made by Portuguese pharmaceutical company Bial, whose tests in France left one person brain dead and five others hospitalized. A spokesman for Johnson & Johnson said in an emailed statement that it voluntarily suspended two mid-stage trials and had not received reports of serious adverse events in its studies of patients with social anxiety disorder and major depressive disorder with anxious distress.